Wolverine Trading, LLC Atossa Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.52 $2,180 - $3,040	-2,000 Reduced 14.18%	12,100 $18,000
Q2 2024 Aug 14, 2024	SELL	$1.03 - $2.1 $2,163 - $4,410	-2,100 Reduced 12.96%	14,100 $16,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.89 $12,960 - $30,618	16,200 New	16,200 $29,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $49,617 - $77,778	-44,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $71,520 - $146,169	44,700 New	44,700 $74,000
Q3 2021 Nov 12, 2021	SELL	$2.89 - $6.4 $551,412 - $1.22 Million	-190,800 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.52 - $8.62 $290,016 - $1.64 Million	190,800 New	190,800 $1.38 Million

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $127M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.